In this segment of The Ellis Martin Report, Ellis speaks with Jerome Jabbour, the CEO of Matinas Biopharma (NYSE:MTNB). The company announced a research collaboration with ViiV Healthcare to evaluate formulation of antiviral drug candidates.
Read More
iSignthis Ltd (ASX:ISX) Paydentity KYC Continues to Drive Applications
iSignthis Ltd (ASX:ISX), is pleased to announce that it has now approved more than 150 reportable accounts. The focus this last month has been on more complex and larger entities, in sectors adjacent to our CFD/FX core markets. Onboarding of approved merchants continues at a pace driven by the merchant integrating to our API's, consistent with our guidance and expectations.
Read More
